References
- O'Grady J. Acute liver failure. Comprehensive clinical hepatology1st ed, J O'Grady, J Lake, P Howdle. Mosby, London 2000; 1–20
- O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439–5
- Dhiman R, Seth A, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998; 43: 1311–6
- Uribe M, Buckel E, Ferrario M, Godoy J, Blanco A, Hunter B, et al. Epidemiology and results of liver transplantation for acute liver failure in Chile. Transplant Proc 2003; 35: 2511–2
- Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med. 2007; 262: 393–401
- Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947–55
- Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003; 23: 217–26
- Brandsaeter B, Höckerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation – 12 years’ experience in the Nordic countries. Liver Transpl 2002; 8: 1055–62
- Ferrac ML, Silvia AE, Macdonald GA, Tsarev SA, Di Biscelgie AM, Lucey MR. Fulminant hepatitis in patients undergoing liver transplantation: evidence for a non-A, non-B, non-C, non-D, and non-E syndrome. Liver Transpl Surg 1996; 2: 60–6
- Rochling FA, Jones WF, Chau K, DuCharme L, Mimms LT, Moore B, et al. Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis. Hepatology 1997; 25: 478–83
- Ben-Ari Z, Samuel D, Zemel R, Baruch Y, Gigou M, Sikuler E, et al. Fulminant non A-G viral hepatitis leading to liver transplantation. Arch Intern Med 2000; 160: 388–92
- Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Themeau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464–70
- Kremers WK, van Ijperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004; 39: 764–9
- Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007; 47: 664–70